438 related articles for article (PubMed ID: 17950572)
1. Gene expression profiling in the adult Down syndrome brain.
Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
[TBL] [Abstract][Full Text] [Related]
2. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
Cheon MS; Dierssen M; Kim SH; Lubec G
Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181
[TBL] [Abstract][Full Text] [Related]
3. [Screening and identification of human chromosome 21 genes resulting in abnormal development of fetal cerebral cortex with Down syndrome].
Yu WD; Liang R; Yang LJ; Shang M; Shen H; Guan J; Guo JZ
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2759-63. PubMed ID: 18167266
[TBL] [Abstract][Full Text] [Related]
4. D-Serine exposure resulted in gene expression changes implicated in neurodegenerative disorders and neuronal dysfunction in male Fischer 344 rats.
Davidson ME; Kerepesi LA; Soto A; Chan VT
Arch Toxicol; 2009 Aug; 83(8):747-62. PubMed ID: 19212759
[TBL] [Abstract][Full Text] [Related]
5. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I).
Cheon MS; Kim SH; Yaspo ML; Blasi F; Aoki Y; Melen K; Lubec G
Amino Acids; 2003; 24(1-2):111-7. PubMed ID: 12624742
[TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor protein expression is upregulated in adipocytes in obesity.
Lee YH; Tharp WG; Maple RL; Nair S; Permana PA; Pratley RE
Obesity (Silver Spring); 2008 Jul; 16(7):1493-500. PubMed ID: 18483477
[TBL] [Abstract][Full Text] [Related]
7. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
[TBL] [Abstract][Full Text] [Related]
8. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
9. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
10. Proteomic signatures and aberrations of mouse embryonic stem cells containing a single human chromosome 21 in neuronal differentiation: an in vitro model of Down syndrome.
Kadota M; Nishigaki R; Wang CC; Toda T; Shirayoshi Y; Inoue T; Gojobori T; Ikeo K; Rogers MS; Oshimura M
Neuroscience; 2004; 129(2):325-35. PubMed ID: 15501590
[TBL] [Abstract][Full Text] [Related]
11. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
Rachidi M; Lopes C
Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
[TBL] [Abstract][Full Text] [Related]
12. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).
Cheon MS; Kim SH; Ovod V; Kopitar Jerala N; Morgan JI; Hatefi Y; Ijuin T; Takenawa T; Lubec G
Amino Acids; 2003; 24(1-2):127-34. PubMed ID: 12624744
[TBL] [Abstract][Full Text] [Related]
13. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
[TBL] [Abstract][Full Text] [Related]
14. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.
Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M
Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279
[TBL] [Abstract][Full Text] [Related]
15. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
16. Molecular mapping of Alzheimer-type dementia in Down's syndrome.
Prasher VP; Farrer MJ; Kessling AM; Fisher EM; West RJ; Barber PC; Butler AC
Ann Neurol; 1998 Mar; 43(3):380-3. PubMed ID: 9506555
[TBL] [Abstract][Full Text] [Related]
17. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
Rachidi M; Lopes C
Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
[TBL] [Abstract][Full Text] [Related]
18. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II).
Cheon MS; Bajo M; Kim SH; Claudio JO; Stewart AK; Patterson D; Kruger WD; Kondoh H; Lubec G
Amino Acids; 2003; 24(1-2):119-25. PubMed ID: 12624743
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of individual cases reveals consistent transcriptional changes in alcoholic human brain.
Liu J; Lewohl JM; Dodd PR; Randall PK; Harris RA; Mayfield RD
J Neurochem; 2004 Sep; 90(5):1050-8. PubMed ID: 15312160
[TBL] [Abstract][Full Text] [Related]
20. Using mouse models to explore genotype-phenotype relationship in Down syndrome.
Salehi A; Faizi M; Belichenko PV; Mobley WC
Ment Retard Dev Disabil Res Rev; 2007; 13(3):207-14. PubMed ID: 17910089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
